Direct interaction of human TFIID with the HIV-1 transactivator tat
about
In vitro nuclear interactome of the HIV-1 Tat proteinHIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoterIdentification of functional microRNAs released through asymmetrical processing of HIV-1 TAR elementA cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcriptionCA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcriptionTargeting of the visna virus tat protein to AP-1 sites: interactions with the bZIP domains of fos and jun in vitro and in vivo.Dephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tat-activated HIV-1 transcription.NMR structure of a biologically active peptide containing the RNA-binding domain of human immunodeficiency virus type 1 TatAbsolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytesInhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodiesNovel mechanism and factor for regulation by HIV-1 TatTrans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase IIThe HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase IIBinding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53La autoantigen alleviates translational repression by the 5' leader sequence of the human immunodeficiency virus type 1 mRNAVisna virus Tat protein: a potent transcription factor with both activator and suppressor domainsThe human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzymeHeterogeneous nuclear ribonucleoprotein K is a transcription factorThree functional classes of transcriptional activation domainInteractions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivatorA human primary T-lymphocyte-derived human immunodeficiency virus type 1 Tat-associated kinase phosphorylates the C-terminal domain of RNA polymerase II and induces CAK activityModulation of human immunodeficiency virus 1 replication by interferon regulatory factorsIn vitro interaction of the human immunodeficiency virus type 1 Tat transactivator and the general transcription factor TFIIB with the cellular protein TAPLentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactorTransdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplicationInteraction of human immunodeficiency virus type 1 Tat with a unique site of TFIID inhibits negative cofactor Dr1 and stabilizes the TFIID-TFIIA complexMutations in the carboxy-terminal domain of TBP affect the synthesis of human immunodeficiency virus type 1 full-length and short transcripts similarlyActivation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1Tat gets the "green" light on transcription initiationThe HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitroTat-associated kinase (P-TEFb): a component of transcription preinitiation and elongation complexesFunctional interaction between the HIV transactivator Tat and the transcriptional coactivator PC4 in T cellsActivation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 TatInteraction of the COOH-terminal transactivation domain of p65 NF-kappa B with TATA-binding protein, transcription factor IIB, and coactivatorsAssociation of Tat with purified HIV-1 and HIV-2 transcription preinitiation complexesA novel LBP-1-mediated restriction of HIV-1 transcription at the level of elongation in vitroThe Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKRInhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignansThe human immunodeficiency virus type 1 Tat antagonist, Ro 5-3335, predominantly inhibits transcription initiation from the viral promoterTAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines
P2860
Q21245051-9DB258C5-4F34-4B60-BE0B-BBDE876713C7Q22007982-DF55EFB9-319A-494E-A25D-1EC38A3C375DQ22242847-224273FF-8724-4F64-AF32-20646FAB8657Q24314052-ECEE9B73-8149-46B1-92DF-ABF981A45A47Q24315725-BEBCB50E-2A0D-419D-85DE-87E3DE7A6DCEQ24516921-73F569D1-5A02-4156-9AF9-B836187432A3Q24535568-EA85ED34-61C9-4B23-8789-E3CA07E32638Q24564152-73BE4B47-9916-45A3-97B7-AD41C259E7DBQ24568326-2320481E-7AF9-41B3-B4A2-E40FCE590B33Q24568329-83A550EE-8973-4DA8-BE67-B2FBF2AAA9EBQ24568366-C96D51B6-7766-4DD1-908D-31BE157CDB5EQ24605302-697D4918-2351-4B6D-BDBF-0A039347F8FBQ24605935-81C60DAA-4575-48A2-9794-B2C051007D45Q24609153-A2325307-086F-4223-A1D1-8E17886A6F35Q24645620-F5F590DC-C478-4E0E-BF2F-6F3E346ACE98Q24645727-1371C613-49F6-4ADA-8DFF-E9CBB7334F36Q24646774-2BF11B3D-C1E9-4406-AE3B-23C59C0FFFC8Q24649693-FC602D43-1EBA-4CCD-90CF-A2B6B6C48629Q24649917-27C3D3A3-FAC0-4982-91F2-C40EC4524805Q24671522-A4446E4F-30B7-4739-AE5A-CE30B81DDAA8Q24671693-5B673649-55FD-4815-A013-94AB5DC6E3A7Q24674143-155C4C65-4ADE-437C-80F5-4C1F0D1BFBCEQ24675459-AECC33E3-DBF4-4742-BFB0-A50C21BACD72Q24676286-326010C6-30AF-4F51-B89C-BA70672FF3B7Q24681560-C94391BC-1D80-4ABA-9CB3-D3277BBF6493Q24681921-2EE5ADC9-25EC-4439-B74A-15B91023B5D9Q24682057-4949C7C7-DB3E-439E-8BC7-A6831031C009Q24682560-652EFE11-74BB-44DA-AD0E-1CA2FA52A153Q24815711-755304B9-4574-45D4-BC4E-378ADE0EA3BBQ27486255-086368AE-6A3F-4790-BE64-5EC3A81D8277Q28138220-ACD87E74-BFB4-4D0A-AF0E-FF513343504EQ28140346-040F1897-A217-4659-BE3D-01337359B89AQ28282041-C8458947-F23A-4DC0-AC92-9AA43CFFED80Q28299369-26E9602F-45AA-4930-9E1F-537A9709459AQ28304889-3528B7E4-D458-41ED-8894-133BA0B8CFE3Q28306373-C5374069-58E3-4F35-9552-DD1620E6EFCAQ28306498-B17E12C2-C48B-474F-8C28-BE0DD1B60E7FQ28367369-0EA40D00-A32B-4A72-931D-DB44A29A0C03Q28368856-5BB950F5-D0C2-44E5-A444-C6BEE3C56B31Q28647556-E7D205B2-05AD-46A7-9144-83E8A030DA86
P2860
Direct interaction of human TFIID with the HIV-1 transactivator tat
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Direct interaction of human TFIID with the HIV-1 transactivator tat
@ast
Direct interaction of human TFIID with the HIV-1 transactivator tat
@en
Direct interaction of human TFIID with the HIV-1 transactivator tat
@nl
type
label
Direct interaction of human TFIID with the HIV-1 transactivator tat
@ast
Direct interaction of human TFIID with the HIV-1 transactivator tat
@en
Direct interaction of human TFIID with the HIV-1 transactivator tat
@nl
prefLabel
Direct interaction of human TFIID with the HIV-1 transactivator tat
@ast
Direct interaction of human TFIID with the HIV-1 transactivator tat
@en
Direct interaction of human TFIID with the HIV-1 transactivator tat
@nl
P2093
P3181
P356
P1433
P1476
Direct interaction of human TFIID with the HIV-1 transactivator tat
@en
P2093
C M Chiang
F Kashanchi
J F Duvall
M F Radonovich
R G Roeder
P2888
P3181
P356
10.1038/367295A0
P407
P577
1994-01-20T00:00:00Z
P6179
1015484045